Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis
Translational Stroke Research · 2024
DOI: 10.1007/s12975-023-01161-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Translational Stroke Research, 2024. Verfasst von Yiming Jia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzho…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Interleukin-6, Ischemic Stroke, Arthritis, Rheumatoid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Rheumatoid factor (RF), an established diagnostic biomarker for rheumatoid arthritis (RA), is associated with cardiovascular diseases, but its impact on clinical outcomes of ischemic stroke remains unclear. We aimed to investigate the observational associations between serum RF and prognosis of ischemic stroke, and further examined the genetic associations of RA and its therapeutic strategy, interleukin-6 (IL-6) inhibitor, with prognosis of ischemic stroke. We measured serum RF levels in 3474 Chinese ischemic stroke patients from the China Antihypertensive Trial in Acute Ischemic Stroke. The primary outcome was the composite outcome of death or major disability (modified Rankin Scale score ≥3) at 3 months after stroke onset. Mendelian randomization (MR) analyses were performed to examine the associations of genetically predicted RA and IL-6 inhibition with prognosis of ischemic stroke. During 3 months of follow-up, 866 patients (25.43%) experienced death or major disability. After multivariate adjustment, RF-positive was significantly associated with a high risk of primary outcome (OR, 1.47; 95% CI, 1.08-2.00; P =0.016) compared with RF-negative. The two-sample MR analyses suggested that genetically predicted RA was associated with an increased risk of primary outcome (OR, 1.09; 95% CI, 1.01-1.18; P=0.021), while genetically predicted IL-6 inhibition was associated with a decreased risk of primary outcome (OR, 0.88; 95% CI, 0.77-0.99; P=0.041). We found that positive RF was associated with increased risks of adverse outcomes after atherosclerotic ischemic stroke, and genetically predicted RA and IL-6 inhibition increased and decreased the risks of adverse outcomes after ischemic stroke, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, 199 Renai Road, Industrial Pa…
- Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
- School of Nursing, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Epidemiology, School of Public health, Chongqing Medical University, Chongqing, China.
- Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
- Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. zbzhu@suda.edu.cn.
Zitieren
APA
Jia, Y., Zhang, K., Shi, M., Guo, D., Yang, P., Bu, X., Chen, J., Wang, A., Xu, T., He, J., Zhu, Z., & Zhang, Y. (2024). Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis. Translational Stroke Research. https://doi.org/10.1007/s12975-023-01161-5
Vancouver
Jia Y, Zhang K, Shi M, Guo D, Yang P, Bu X, et al. Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis. Translational Stroke Research. 2024. doi:10.1007/s12975-023-01161-5
BibTeX
@article{Jia2024,
author = {Jia, Yiming and Zhang, Kaixin and Shi, Mengyao and Guo, Daoxia and Yang, Pinni and Bu, Xiaoqing and Chen, Jing and Wang, Aili and Xu, Tan and He, Jiang and Zhu, Zhengbao and Zhang, Yonghong},
title = {Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis},
journal = {Translational Stroke Research},
year = {2024},
doi = {10.1007/s12975-023-01161-5}
}
EUVIMED